Cargando…

地西他滨桥接异基因造血干细胞移植治疗骨髓增生异常综合征的疗效分析

OBJECTIVE: To evaluate the efficacy of decitabine (DAC) bridging therapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with myelodysplastic syndrome (MDS). METHODS: The clinical characteristics and curative effect of MDS patients who received allo-HSCT from 2...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342152/
https://www.ncbi.nlm.nih.gov/pubmed/25778887
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.008